CoPacker Index / Food Brand Daily
Food Brand Daily · Wednesday, October 7, 20261 new federal notice
Today's brief for food and beverage brands, built automatically from public FDA recall reports and the Federal Register. Nothing here is our opinion of any company.
New in the Federal Register
Rules, proposed rules, and notices from the FDA and USDA that touch food, labels, and organic.
- Notice · Health and Human Services Department
Determination That Oxandrin (Oxandrolone) Tablets, 2.5 Milligrams and 10 Milligrams, Were Withdrawn From Sale for Reasons of Safety or Effectiveness; Correction
The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register of September 13, 2023 (88 FR 62799). The notice announced the determination that Oxandrin (oxandrolone) tablets, 2.5 milligrams (mg) and 10 mg, were withdrawn from sale for reasons of safety or effectiveness. The notice did not include the determination that the abbreviated new drug applications (ANDAs) referencing...
Summaries are the agencies' own words. Read the full document before you act on it.
Looking for a certified co-packer?
Describe your product and get a free launch plan with every USDA organic certified co-packer that fits.
Build my launch planSources: openFDA food enforcement reports and the Federal Register API. Recall details are copied from FDA reports and may be updated by the FDA. CoPacker Index is not affiliated with the FDA or USDA.